Integrated genomic analyses of ovarian carcinoma | Nature | 2011 | 5.2K |
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Cancer Cell | 2010 | 4.8K |
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 3.8K |
Integrated genomic characterization of endometrial carcinoma | Nature | 2013 | 2.8K |
Mammalian caspases: structure, activation, substrates, and functions during apoptosis | Annual Review of Biochemistry | 1999 | 2.3K |
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial | Lancet, The | 2016 | 2.3K |
International uniform response criteria for multiple myeloma | Leukemia | 2006 | 2K |
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial | Lancet, The | 2013 | 1.8K |
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer | Annals of Oncology | 2016 | 1.7K |
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 | Annals of Oncology | 2015 | 1.4K |
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship | Mayo Clinic Proceedings | 2008 | 1.3K |
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer | New England Journal of Medicine | 2018 | 1.2K |
Detection and localization of surgically resectable cancers with a multi-analyte blood test | Science | 2018 | 1.2K |
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors | New England Journal of Medicine | 2015 | 1.2K |
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial | Lancet, The | 2017 | 1.2K |
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05 | International Journal of Radiation Oncology Biology Physics | 2000 | 1.2K |
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation | New England Journal of Medicine | 2017 | 1.1K |
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer | Journal of Clinical Oncology | 2010 | 1.1K |
PARP inhibition: PARP1 and beyond | Nature Reviews Cancer | 2010 | 985 |
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma | New England Journal of Medicine | 2015 | 928 |
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17 | Journal of the National Cancer Institute | 2005 | 918 |
Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment | Journal of Clinical Oncology | 2004 | 888 |
Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin | Science | 1997 | 821 |
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial | JAMA - Journal of the American Medical Association | 2016 | 820 |
Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress | Journal of Biological Chemistry | 2001 | 817 |